Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Email subject line: LINE EXTENSION NOTICE-treatment option for chronic immune thrombocytopenia and severe aplastic anemia To: ACCC From: Novartis To ACCC: Novartis Pharmaceuticals Corporation announces that the US Food and Drug Administration approved PROMACTA® (eltrombopag) 25-mg powder for suspension package size on March 23, 2020. Please update your systems with the following packaging …
Home / Current Exhibitors Current Exhibitors ACCC 43rd Annual Meeting - CANCERSCAPE 2017 2017 Exhibitors Here’s a look at the 2017 exhibitors who showcased at the ACCC 43rd Annual Meeting, CANCERSCAPE. If you are interested in exhibiting or reserving a booth space at a future meeting or conference, please contact Mal Milburn, Exhibit Manager, at 301.984.5074 or email …
Because interdisciplinary teams become specialists in treating certain disease sites, it is important to develop distress screening guidelines that best serve specific patient populations and their treatment.
Half of survey respondents say that their EHR has “slightly decreased” the time providers are able to spend with patients; 16% report clinician time with patients has “significantly decreased” after EHR adoption. Highlights from the 2017 Trending Now in Cancer Care Survey A joint survey of the Association of Community Cancer Centers (ACCC) and the Advisory Board Oncology …
SCOS ONCOLOGY DRUG NEWSLETTER D E C E M B E R 2 0 2 3 FDA APPROVALS Capivasertib (Truqap) and Fulvestrant (Faslodex) Combination The FDA granted approval to the combination of capivasertib (Truqap) and fulvestrant (Faslodex) for the treatment of adult patients with hormone receptor– positive, HER2-negative, locally advanced or metastatic breast cancer that harbors 1 or more PIK3CA, …
JF11-Issues
Presented at IASLC 2018 World Conference on Lung Cancer in Toronto, Canada
Pandemic Planning Clinical Guideline for Patients with Cancer March 10 2020 2 Pandemic Planning Clinical Guideline for Patients with Cancer Contents INTRODUCTION .................................................................................................. 4 Planning Assumptions …
Again this year oncology practices and cancer programs scramble to update their respective chargemasters, fee schedules, and other reimbursement documents to ensure compliance with coding and billing guidelines.
SCOS ONCOLOGY DRUG NEWSLETTER O C T O B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Motixafortide (Aphexda) The FDA has granted approval to motixafortide (Aphexda) used in combination with filgrastim granulocyte-colony stimulating factor …
NCOA ONCOLOGY DRUG NEWSLETTER O C T O B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Motixafortide (Aphexda) The FDA has granted approval to motixafortide (Aphexda) used in combination with filgrastim granulocyte-colony stimulating factor …
TACOS ONCOLOGY DRUG NEWSLETTER O C T O B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Motixafortide (Aphexda) The FDA has granted approval to motixafortide (Aphexda) used in combination with filgrastim granulocyte-colony stimulating factor …
BiomarkerLIVE Biomarker Testing in Practice: Process Improvement Toolkit 1 INTRODUCTION Multiple challenges arise when attempting to integrate biomarker testing into community oncology practices. This toolkit focuses on four key elements that must be taken into account when developing a precision medicine program that incorporates biomarker testing: 1. Provider Education 2. Patient …
Cancer-Care-Trends-2012
Year three of the Association of Community Cancer Centers' member survey provides insight into how cancer programs are working to control costs, implement new standards, launch new organizational strategies, and better serve patients. Christian Downs, JD, MHA Executive Director, ACCC Cancer Care Trends in Community Cancer Centers – A Survey of ACCC Membership 2012 …
MA14-Rescue-Lung-Rescue-Life
FAN-Medical-Debt-Among-People-with-Health-Insurance
ACCC-Media-Planner-2016
ACCC-Media-Guide-2013
PowerPoint Presentation 1 CONFIDENTIAL – Contains proprietary information. Not intended for external distribution. Optimizing Professional Wellness: Navigating Workplace Experiences in Healthcare Ishwaria M. Subbiah, M.D., M.S. Executive Director, Cancer Care Equity and Professional Wellness, SCRI Medical Director, Supportive Care Oncology, Health Equity, and Professional Well-being …